News

Filter

Current filters:

None

76 to 85 of 96292 results

Pharma partnerships vital in stagnant Alzheimer’s treatment market, says analyst

Pharma partnerships vital in stagnant Alzheimer’s treatment market, says analyst

24-09-2014

US pharma major Eli Lilly’s recent partnership with Anglo-Swedish peer AstraZeneca to develop oral…

AstraZenecaAZD3293Eli LillyLicensingNeurologicalPharmaceuticalResearch

AstraZeneca’s Byetta meets primary endpoint in diabetes trial and reduces weight

AstraZeneca’s Byetta meets primary endpoint in diabetes trial and reduces weight

24-09-2014

UK-based pharma major AstraZeneca has announced new research showing that Byetta (exenatide) added to…

AstraZenecaByettaDiabetesGlucagonPharmaceuticalResearchUK

FDA accepts NDA filing for Lundbeck and Otsuka's brexpiprazole

FDA accepts NDA filing for Lundbeck and Otsuka's brexpiprazole

24-09-2014

The US Food and Drug Administration has accepted the filing for review of brexiprazole for the treatment…

CNS DiseasesLundbeckOtsukaPharmaceuticalRegulationUSA

Statins can lead to increased survival after hemorrhagic stroke, study finds

Statins can lead to increased survival after hemorrhagic stroke, study finds

24-09-2014

Patients who were treated with a statin in hospital after suffering from a hemorrhagic stroke were significantly…

Cardio-vascularHealthHemorrhagic strokePharmaceuticalResearchStatinStrokeUSA

Actavis approached by Pfizer in latest takeover deal, according to sources

Actavis approached by Pfizer in latest takeover deal, according to sources

24-09-2014

US pharma giant Pfizer has held talks regarding an acquisition of Ireland-headquartered generics major…

ActavisMergers & AcquisitionsPfizerPharmaceuticalUSA

FDA fast track designation for AstraZeneca’s MEDI3902

FDA fast track designation for AstraZeneca’s MEDI3902

24-09-2014

Anglo-Swedish pharma major AstraZeneca’s global biologics R&D arm, MedImmune has received fast track…

Antibiotics and Infectious diseasesAstraZenecaBiotechnologyMEDI3902MedImmuneRegulationUSA

Celgene’s psoriasis drug Otezla gains FDA approval

Celgene’s psoriasis drug Otezla gains FDA approval

24-09-2014

The US Food and Drug Administration has approved biotech major Celgene’s Otezla (apremilast), an oral,…

BiotechnologyCelgene Corp.DermatologicalsOtezlaRegulationUSA

Decline in sales rep access makes digital communications vital, says ZS report

Decline in sales rep access makes digital communications vital, says ZS report

24-09-2014

Digital communication channels are becoming increasingly important as cost pressures mean drug reps reduce…

BusinessMarkets & MarketingPharmaceuticalResearchUnited StatesUSA

76 to 85 of 96292 results

Back to top